Physician profile
Keyvan Ganz
NPI 1538104096
$3,308.39
in general payments reported to CMS, 2019-2025
22 companies · $751 in 2025
The $751 reported for 2025 was more than what 76% of Sports Medicine (Podiatrist) providers received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,776 · 2020: $146 · 2021: $106 · 2022: $57.15 · 2023: $371 · 2024: $101 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $679 · Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $679.32 |
| Food and Beverage | $544.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $822.70 | 2019 | |
| Treace Medical Concepts, INC. | $709.37 | 2025 | |
| Wright Medical Technology, INC. | $371.20 | 2019-2020 | |
| Horizon Therapeutics Plc | $245.84 | 2019-2023 | Krystexxa |
| Stryker Corporation | $236.55 | 2021-2023 | Ortholoc 3di Crosscheck |
| Depuy Synthes Sales INC. | $232.43 | 2019-2024 | |
| Melinta Therapeutics, LLC | $152.00 | 2019-2020 | |
| Medtronic Vascular, INC. | $116.59 | 2019 | |
| Sandoz INC. | $84.65 | 2019 | |
| Smith+Nephew, INC. | $70.69 | 2019-2022 | |
| Zyla Life Sciences, INC. | $41.39 | 2019 | |
| Averitas Pharma INC. | $38.25 | 2024 | Qutenza |
| Lifenet Health | $23.71 | 2024 | Theragenesis Wound Matrix |
| Biotronik Nro, INC. | $22.69 | 2025 | Prospera |
| Merck Sharp & Dohme LLC | $22.47 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $21.59 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.40 | 2024 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $19.00 | 2025 | |
| Novum Pharma, LLC | $17.36 | 2019 | |
| Kci USA, INC. | $14.19 | 2019 | |
| Tactile Systems Technology INC | $13.50 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyvan Ganz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.